Smith+Nephew Introduces FLOW FLEXTEND COBLATION Wand for Hip Procedures

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces a breakthrough in RF resection technology for hip with its new FLOW FLE...

August 19, 2026 | Wednesday | News
Evaxion Expands Cancer Vaccine Pipeline with EVX-05 for Glioblastoma

EVX-05 is an off-the-shelf therapeutic glioblastoma (brain cancer) vaccine designed based on patient tumor samples. It targets novel conserved antigens...

August 19, 2026 | Wednesday | News
Pfizer and Valneva Lyme Disease Vaccine Application Validated by EMA

Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA)  announced that the European Medicines Agency (EMA) has validated the Mar...

August 18, 2026 | Tuesday | News
CellCarta Adds Tempus AI to CDx Commercialization Lab Network

CellCarta, a global CRO laboratory supporting the biopharmaceutical industry, announced a strategic collaboration with Tempus AI, Inc. (NASDAQ: TEM). Under...

August 13, 2026 | Thursday | News
SciSparc Highlights NeuroThera’s Quantum Analytics Milestone for Clinical Trial Data

SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”),  announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a ...

August 04, 2026 | Tuesday | News
Delivering Genetic Medicines Where They Matter Most

Targeted genetic medicines are reshaping the future of cancer treatment by improving the precision of therapeutic delivery while addressing the challenges ...

August 03, 2026 | Monday | Expert Opinion
NeuroPace to Work with FDA After PMA Supplement for IGE Indication Receives Non-Approvable Letter

-- Company received communication from FDA indicating that the PMA Supplement for idiopathic generalized epilepsy is not approvable in its current form...

July 30, 2026 | Thursday | News
Verastem Oncology Dosed First Patient in Phase 2 TARGET-D 203 Trial of VS-7375 for Metastatic Colorectal Cancer

TARGET-D 203 trial to evaluate VS-7375 both as monotherapy and in combination with cetuximab or panitumumab in previously treated metastatic colorectal...

July 30, 2026 | Thursday | News
Nova Biomedical Expands Cell Line Development Portfolio with NanoCellect Asset Acquisition

Nova Biomedical announced a transaction involving certain assets of NanoCellect, a provider of microfluidic cell sorting technology. This expands Nova Bio...

July 27, 2026 | Monday | News
Aptar Pharma’s Nanopharm Facility Earns MHRA GMP Certification

  Aptar Pharma, a global leader in drug delivery, dosing, protection technologies and services,  announced that the UK Medicines and Healthcare ...

July 24, 2026 | Friday | News
Quintara Biosciences Relocates Boston-Area Laboratory to Watertown to Expand Sequencing Capacity

As a strategic step to better support growing demand and strengthen future service capacity, Quintara Biosciences announced that its Boston area laboratory...

June 15, 2026 | Monday | News
Verge Labs and Tenacia Biotechnology Forge Strategic Partnership to Advance CNS Drug Development with Human Tissue Data and AI

First partnership announced under Verge Labs' platform-first model; Tenacia will apply Verge's AI platform and proprietary multimodal...

June 11, 2026 | Thursday | News
Phenomenex Launches Luna Omega HILIC LC Columns to Advance High-Performance Separation of Polar Compounds

Phenomenex Inc., a Danaher Company and a global leader in the research and manufacture of advanced technologies for the separation sciences, announced th...

June 10, 2026 | Wednesday | News
Phenomenex Launches Endrix Long Life LC Column to Enhance Durability and Analytical Consistency

Phenomenex Inc., a Danaher Company and a global leader in the research and manufacture of advanced technologies for the separation sciences,  introd...

June 04, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close